![Rasmus Holm-Jorgensen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Rasmus Holm-Jorgensen
Plus aucun poste en cours
Fortune : 41 741 $ au 31/05/2026
Profil
Mr. Rasmus Holm-Jorgensen was previously employed as a Chief Financial Officer by Acrivon Therapeutics, Inc., a Chief Strategy & Portfolio Officer by Kiniksa Pharmaceuticals Ltd., and a Group Vice President & General Manager by Synageva BioPharma Corp.
He received his graduate degree from the University of Copenhagen.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 01/03/2025 | 26 088 ( 0,06% ) | 41 741 $ | 31/05/2026 |
Anciens postes connus de Rasmus Holm-Jorgensen
| Sociétés | Poste | Fin |
|---|---|---|
| ACRIVON THERAPEUTICS, INC. | Directeur Financier/CFO | 01/04/2025 |
Kiniksa Pharmaceuticals Ltd.
 Kiniksa Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and delivers therapeutic medicines for patients suffering from cardiovascular diseases | Fondateur | 01/04/2022 |
| SYNAGEVA BIOPHARMA CORP | Corporate Officer/Principal | 01/01/2015 |
Formation de Rasmus Holm-Jorgensen
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
28
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
University of Copenhagen
 University of Copenhagen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Synageva BioPharma Corp.
 Synageva BioPharma Corp. BiotechnologyHealth Technology Develops and manufactures biopharmaceutical products | Health Technology |
Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and delivers therapeutic medicines for patients suffering from cardiovascular diseases | Health Technology |
Acrivon Therapeutics, Inc.
 Acrivon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops and sells precision oncology medicines | Health Technology |
Choisissez Zonebourse 
